Search research articles
Contact Us
Filters
Showing results (131-140 of 175) with videos related to
Page
of 18
Sort By:
Molecular Genetics and Metabolism
|
June 27, 2002
The role of the HNF4alpha enhancer in type 2 diabetes
Simon M S Mitchell, Anna L Gloyn, Katharine R Owen, et al.
Cancer Research
|
October 15, 1988
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant
M S Mitchell, J Kan-Mitchell, R A Kempf, et al.
The Journal of Investigative Dermatology
|
February 1, 1986
Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections
A Imam, M S Mitchell, R L Modlin, et al.
Cancer
|
July 1, 1973
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L
R T Skeel, J C Marsh, R C DeConti, et al.
Journal of the National Cancer Institute
|
February 1, 1980
Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity
M B Mokyr, J A Bennett, D P Braun, et al.
The Ulster Medical Journal
|
July 26, 2002
Successful colonoscopy; completion rates and reasons for incompletion
R M S Mitchell, K McCallion, K R Gardiner, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Reactivity of a human monoclonal antibody against carcinomas and other lesions of the colon
S C Formenti, M S Mitchell, C R Taylor, et al.
Surgery
|
September 1, 1982
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities
S Ariyan, J M Kirkwood, M S Mitchell, et al.
Cancer Research
|
September 1, 1984
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil
C P Spears, B G Gustavsson, M S Mitchell, et al.
Cancer Investigation
|
January 1, 1984
Kaposi's sarcoma and autoimmune thrombocytopenia
R L Modlin, R A Kempf, M S Mitchell, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 175) with videos related to
Sort By:
Page
of 18
Molecular Genetics and Metabolism
|
June 27, 2002
The role of the HNF4alpha enhancer in type 2 diabetes
Simon M S Mitchell, Anna L Gloyn, Katharine R Owen, et al.
Cancer Research
|
October 15, 1988
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant
M S Mitchell, J Kan-Mitchell, R A Kempf, et al.
The Journal of Investigative Dermatology
|
February 1, 1986
Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections
A Imam, M S Mitchell, R L Modlin, et al.
Cancer
|
July 1, 1973
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L
R T Skeel, J C Marsh, R C DeConti, et al.
Journal of the National Cancer Institute
|
February 1, 1980
Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity
M B Mokyr, J A Bennett, D P Braun, et al.
The Ulster Medical Journal
|
July 26, 2002
Successful colonoscopy; completion rates and reasons for incompletion
R M S Mitchell, K McCallion, K R Gardiner, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Reactivity of a human monoclonal antibody against carcinomas and other lesions of the colon
S C Formenti, M S Mitchell, C R Taylor, et al.
Surgery
|
September 1, 1982
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities
S Ariyan, J M Kirkwood, M S Mitchell, et al.
Cancer Research
|
September 1, 1984
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil
C P Spears, B G Gustavsson, M S Mitchell, et al.
Cancer Investigation
|
January 1, 1984
Kaposi's sarcoma and autoimmune thrombocytopenia
R L Modlin, R A Kempf, M S Mitchell, et al.
Page
of 18